Literature DB >> 25936672

Living kidney donors and ESRD.

Lainie Friedman Ross1.   

Abstract

There are more than 325 living kidney donors who have developed end-stage renal disease and have been listed on the Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) deceased donor kidney wait list. The OPTN/UNOS database records where these kidney donors are listed and, if they donated after April 1994, where that donation occurred. These 2 locations are often not the same. In this commentary, I examine whether a national living donor registry should be created and whether transplantation centers should be notified when one of their living kidney donors develops end-stage renal disease. I consider and refute 5 potential objections to center notification. I explain that transplantation centers should look back at these cases and input data into a registry to attempt to identify patterns that could improve donor evaluation protocols. Creating a registry and mining the information it contains is, in my view, our moral and professional responsibility to future patients and the transplantation endeavor. As individuals and as a community, we need to acknowledge the many unknown risks of living kidney donation and take responsibility for identifying these risks. We then must share information about these risks, educate prospective donors about them, and attempt to minimize them.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Living donors; Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS); donor registry; donor risks; duty to look back; end-stage renal disease (ESRD); kidney; transplantation

Mesh:

Year:  2015        PMID: 25936672      PMCID: PMC4485582          DOI: 10.1053/j.ajkd.2015.01.032

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  16 in total

1.  Ghost charts and shadow records: implication for system design.

Authors:  Ellen Balka
Journal:  Stud Health Technol Inform       Date:  2010

2.  Screening for sickle trait among potential live kidney donors: policies and practices in US transplant centers.

Authors:  Peter Philip Reese; Aaron Christopher Hoo; Colm Christopher Magee
Journal:  Transpl Int       Date:  2007-12-13       Impact factor: 3.782

3.  We need a registry of living kidney donors.

Authors:  Lainie Friedman Ross; Mark Siegler; J Richard Thistlethwaite
Journal:  Hastings Cent Rep       Date:  2007 Nov-Dec       Impact factor: 2.683

4.  Raising the bar for medically complex donors.

Authors:  Seth A Waits; Randall S Sung
Journal:  Transplantation       Date:  2014-04-15       Impact factor: 4.939

5.  Eighth report of the Human Kidney Transplant Registry.

Authors:  J E Murray; B A Barnes; J C Atkinson
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

6.  Estimating risks of de novo kidney diseases after living kidney donation.

Authors:  R W Steiner; J H Ix; D E Rifkin; B Gert
Journal:  Am J Transplant       Date:  2014-03       Impact factor: 8.086

7.  Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.

Authors:  Richard R Fabsitz; Amy McGuire; Richard R Sharp; Mona Puggal; Laura M Beskow; Leslie G Biesecker; Ebony Bookman; Wylie Burke; Esteban Gonzalez Burchard; George Church; Ellen Wright Clayton; John H Eckfeldt; Conrad V Fernandez; Rebecca Fisher; Stephanie M Fullerton; Stacey Gabriel; Francine Gachupin; Cynthia James; Gail P Jarvik; Rick Kittles; Jennifer R Leib; Christopher O'Donnell; P Pearl O'Rourke; Laura Lyman Rodriguez; Sheri D Schully; Alan R Shuldiner; Rebecca K F Sze; Joseph V Thakuria; Susan M Wolf; Gregory L Burke
Journal:  Circ Cardiovasc Genet       Date:  2010-12

8.  Long-term risks for kidney donors.

Authors:  Geir Mjøen; Stein Hallan; Anders Hartmann; Aksel Foss; Karsten Midtvedt; Ole Øyen; Anna Reisæter; Per Pfeffer; Trond Jenssen; Torbjørn Leivestad; Pål-Dag Line; Magnus Øvrehus; Dag Olav Dale; Hege Pihlstrøm; Ingar Holme; Friedo W Dekker; Hallvard Holdaas
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

9.  Return of genomic results to research participants: the floor, the ceiling, and the choices in between.

Authors:  Gail P Jarvik; Laura M Amendola; Jonathan S Berg; Kyle Brothers; Ellen W Clayton; Wendy Chung; Barbara J Evans; James P Evans; Stephanie M Fullerton; Carlos J Gallego; Nanibaa' A Garrison; Stacy W Gray; Ingrid A Holm; Iftikhar J Kullo; Lisa Soleymani Lehmann; Cathy McCarty; Cynthia A Prows; Heidi L Rehm; Richard R Sharp; Joseph Salama; Saskia Sanderson; Sara L Van Driest; Marc S Williams; Susan M Wolf; Wendy A Wolf; Wylie Burke
Journal:  Am J Hum Genet       Date:  2014-05-08       Impact factor: 11.025

10.  Risk of end-stage renal disease following live kidney donation.

Authors:  Abimereki D Muzaale; Allan B Massie; Mei-Cheng Wang; Robert A Montgomery; Maureen A McBride; Jennifer L Wainright; Dorry L Segev
Journal:  JAMA       Date:  2014-02-12       Impact factor: 56.272

View more
  2 in total

1.  A Case-Based Analysis of Whether Living Related Donors Listed for Transplant Share ESRD Causes with Their Recipients.

Authors:  Arthur J Matas; Rebecca E Hays; Hassan N Ibrahim
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-01       Impact factor: 8.237

2.  Campaigning for Organ Donation at Mosques.

Authors:  Mohamed Y Rady; Joseph L Verheijde
Journal:  HEC Forum       Date:  2016-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.